Milestone Pharmaceuticals (MIST) Debt Ratio (2023 - 2026)

Milestone Pharmaceuticals' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.3 for Q1 2026.

• Quarterly Debt Ratio fell 65.76% year-over-year to 0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.3 (down 65.76% YoY) and the FY2025 annual result came in at 0.5, down 28.73% from the prior year.
• Debt Ratio was 0.3 for Q1 2026 at Milestone Pharmaceuticals, down from 0.5 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.16 in Q2 2025 and bottomed at 0.3 in Q1 2026.
• A 4-year average of 0.62 and a median of 0.58 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2025 — Debt Ratio soared 101.72% — and 2026, when it plunged 65.76%.
• Milestone Pharmaceuticals' Debt Ratio stood at 0.66 in 2023, then advanced by 6.81% to 0.71 in 2024, then fell by 28.73% to 0.5 in 2025, then tumbled by 40.36% to 0.3 in 2026.
• Business Quant data shows MIST's Debt Ratio at 0.3 in Q1 2026, 0.5 in Q4 2025, and 0.64 in Q3 2025.